The Role of cf-HPV DNA as an Innovative Biomarker for Predicting the Recurrence or Persistence of Cervical Cancer
cf-HPV DNA in plasma is a promising biomarker for post-treatment surveillance, facilitating the earlier detection of persistence/recurrence. Incorporating this biomarker into clinical protocols could enhance outcomes and survival, particularly in underserved regions like the Amazon, where the access to healthcare is limited.
Authors
- Kátia Luz Torres (ORCID: https://orcid.org/0000-0003-0922-5866)
- Lílian Santos Pinheiro (ORCID: https://orcid.org/0000-0003-2957-7674)
- Valquíria do Carmo Alves Martins (ORCID: https://orcid.org/0000-0003-1259-9738)
- José Eduardo Levi (ORCID: https://orcid.org/0000-0002-3557-2717)
- Daniel Lourenço Lira
- Heidy Halanna de Melo Farah Rondon (ORCID: https://orcid.org/0000-0002-0110-6486)
- Mikele Praia de Oliveira
- Flávia Níniver O. Gomes
- Higino Felipe Figueiredo (ORCID: https://orcid.org/0000-0001-8964-810X)
- L. Dias (ORCID: https://orcid.org/0000-0003-4755-2008)
- Jhonnatan Silva de Souza
- Márcia Poinho
Institutions
- Fundação de Medicina Tropical (BR)
- Fundação de Amparo à Pesquisa do Estado do Amazonas (BR)
- Universidade Federal do Amazonas (BR)
Publication Details
- Journal
- Viruses
- Published
- 2025-03-13
- DOI
- https://doi.org/10.3390/v17030409
- Citations
- 3
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 4.06
Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico